Growth Hormone Treatment Clinical Trial
Official title:
Evolution of the Quality of Life of Short Stature Children Treated With Growth Hormone : Evaluation at Adult Size
Short stature can lead to emotional and social stress in children and adolescents, as well as their parents. Children and their parents want to be able to identify the cause of stunted growth and address it with treatment. Mitigating the impact of short stature on quality of life is one of the main goals of treatment. The quality of life in children can be measured using adapted self-questionnaires. The investigative team published in 2019 the results of a preliminary study which shows that after one year of treatment with growth hormone, the quality of life improves in children, in particular on the scales emotional and social. These evaluations were carried out in particular thanks to the general questionnaire of quality of life: Pediatric Quality of Life Inventory (PedsQL) 4.0, but also via a specific questionnaire of the size: Quality of Life of Short Stature Youth questionnaire (QoLiSSY). 50 of the 74 patients who participated in this study have now reached their final height. The objective of the present study is to reassess this cohort using the QoLiSSY and PedsQL 4.0 questionnaires. The patient will be his own witness.
Short stature can lead to emotional and social stress in children and adolescents, as well as their parents. Children and their parents want to be able to identify the cause of stunted growth and address it with treatment. Mitigating the impact of short stature on quality of life is one of the main goals of treatment. The quality of life in children can be measured using adapted self-questionnaires. The investigative team published in 2019 the results of a preliminary study which shows that after one year of treatment with growth hormone, the quality of life improves in children, in particular on the scales emotional and social. These evaluations were carried out in particular thanks to the general questionnaire of quality of life: Pediatric Quality of Life Inventory (PedsQL) 4.0, but also via a specific questionnaire of the size: Quality of Life of Short Stature Youth questionnaire (QoLiSSY). 50 of the 74 patients who participated in this study have now reached their final height. The objective of the present study is to reassess this cohort using the QoLiSSY and PedsQL 4.0 questionnaires. The patient will be his own witness. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02987868 -
Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine
|
N/A | |
| Recruiting |
NCT03431727 -
Acromegaly - Before and After Treatment
|
||
| Completed |
NCT03038594 -
Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
|
Phase 2/Phase 3 | |
| Completed |
NCT03203356 -
Adrenal Function in GHD Children
|
N/A | |
| Completed |
NCT02782221 -
Lipolytic Effects of GH in Human Subjects in Vivo
|
N/A | |
| Completed |
NCT05105685 -
Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS
|
Phase 1/Phase 2 | |
| Completed |
NCT04244123 -
Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
|
||
| Not yet recruiting |
NCT03005561 -
Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
|
N/A | |
| Recruiting |
NCT06448195 -
Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery
|
Phase 4 | |
| Completed |
NCT03033121 -
Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children
|
Phase 3 | |
| Not yet recruiting |
NCT05660356 -
Growth Hormone Deficiency in Mild Traumatic Brain Injury
|
Early Phase 1 | |
| Active, not recruiting |
NCT00867971 -
Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?
|
N/A | |
| Recruiting |
NCT05253287 -
Growth Hormone in Decompensated Liver Cirrhosis
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT03091374 -
Impact of Recombinant Human Growth Hormone on HIV Persistence
|
Phase 2 | |
| Not yet recruiting |
NCT02326610 -
Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae
|
Phase 2 | |
| Recruiting |
NCT06103513 -
Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children
|
Phase 3 | |
| Recruiting |
NCT04938466 -
Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
|
||
| Recruiting |
NCT06037473 -
The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
|
||
| Recruiting |
NCT05144035 -
A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants
|
Phase 4 | |
| Recruiting |
NCT03878992 -
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
|
N/A |